These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 5764028)

  • 1. Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin.
    Zucker S; Cathey MH
    J Lab Clin Med; 1969 Feb; 73(2):320-6. PubMed ID: 5764028
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring of heparin therapy in thromboembolism].
    Hiller E
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1367-70. PubMed ID: 4716792
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of action and monitoring of anticoagulants.
    Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):1-11. PubMed ID: 3961504
    [No Abstract]   [Full Text] [Related]  

  • 5. [Informative value of control methods for postoperative supervision of medication with aspirin and heparin (author's transl)].
    Schöndorf TH; Hey D
    MMW Munch Med Wochenschr; 1977 Jan; 119(4):119-22. PubMed ID: 402555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local heparin is superior to systemic heparin in preventing arterial thrombosis.
    Andresen DM; Barker JH; Hjortdal VE
    Microsurgery; 2002; 22(6):265-72. PubMed ID: 12375294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring heparin therapy with the activated partial thromboplastin time.
    Stuart RK; Michel A
    Can Med Assoc J; 1971 Mar; 104(5):385-8. PubMed ID: 5557913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of external electrical stimulation on laser-beam-induced experimental thrombosis.
    Aguejouf O; Doutremepuich F; Doutremepuich C
    Pathophysiol Haemost Thromb; 2006; 35(5):364-9. PubMed ID: 17230037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
    Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory control of heparin therapy with the activated partial thromboplastin time test.
    Degnan TJ; Karasik S; Lenahan J
    Curr Ther Res Clin Exp; 1969 Jun; 11(6):390-6. PubMed ID: 4979988
    [No Abstract]   [Full Text] [Related]  

  • 13. Laboratory monitoring of heparin. Effect of reagents and instruments on the activated partial thromboplastin time.
    Brandt JT; Triplett DA
    Am J Clin Pathol; 1981 Oct; 76(4 Suppl):530-7. PubMed ID: 7282639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory control of anticoagulant treatments (author's transl)].
    Samama M; Conard J; Horellou MH
    J Mal Vasc; 1981; 6(4):257-61. PubMed ID: 7320641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig.
    Himber J; Refino CJ; Burcklen L; Roux S; Kirchhofer D
    Thromb Haemost; 2001 Mar; 85(3):475-81. PubMed ID: 11307818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional versus systemic heparinization.
    Shin CS; Chaudhry AG; Elizalde A; Sittisuntorn O
    Surg Gynecol Obstet; 1979 Jun; 148(6):913-6. PubMed ID: 451813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of intraoperative heparinization in vascular surgery.
    Manny J; Romanoff H; Hyam E; Manny N
    Surgery; 1976 Nov; 80(5):641-3. PubMed ID: 982283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin monitoring in acute thrombosis associated with antiphospholipid antibody syndrome.
    Wittkowsky AK; Kino KJ
    Pharmacotherapy; 1995; 15(4):517-21. PubMed ID: 7479207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Theoretical basis and practical carrying out of an APTT control test for exact heparin monitoring (author's transl)].
    Vogel GE
    Med Klin; 1977 Feb; 72(6):207-11. PubMed ID: 840137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is the activated partial thromboplastin time suitable for monitoring of thrombosis therapy with high-dose standard heparin?].
    Hürzeler C; von Felten A
    Schweiz Med Wochenschr; 1994 Apr; 124(17):712-9. PubMed ID: 8202668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.